Oncology Books
Elsevier - Health Sciences Division Clinical ImmunoOncology
Book SynopsisTable of ContentsTentative TOC: Introduction: Chapter 1.0 Development and Structure of the Lymphoid System embryologic development gross anatomy of the human immune system lymphatic endothelial cells, heterogeneity of, and lymph node microscopic structure lymph node function; afferent lymph cellular components role of the gut microbiome in immune system development specific functions related to the spread of cancer cancer-induced lymphangiogeneis; sentinel LNs Chapter 2.0 The Chemistry, Structure, and Function of Immunoglobulins immunoglobulin isotypes the structure of immunoglobulins the genetics of immunoglobulin diversity antibody-dependent cellular cytotoxicity heavy-chain C domain and role of glycosylation the development of humanized monoclonals Chapter 3.0 The Role of the Complement System in Cancer complement system activation pathways (classical, alternative and lectin) the role of complement activation in cancer progression complement regulatory proteins (CRPs) and cancer the role of compliment activation in the tumor microenvironment enhances tumor growth complement-dependent cytotoxicity in immune therapy of cancer formation of the membrane attack complex (MAC) potential application of anti-complement cancer therapies (C3aR/C5aR/IL-10 pathway) Chapter 4.0 Cancer as Non-Self 4.1 primary generator of tumor-specific transplantation type antigens 4.2 character of non-self, tumor associated antigens 4.3 immune surveillance - innate immunity 4.4 distinguishing between self and non-self 4.5 toll-like receptors (TLRs); soluble bioactive proteins such as cytokines and C' proteins 4.6 NK cells Chapter 5.0 The Adaptive Immune Response in Cancer the diversity of active tumor antigen receptors target specificity without limits in cancer-receptor variability tumor antigen presentation; dendritic cells immune response stimulation against the cancer Cytotoxic T-cells and T-regulatory cells B-cells and antibodies Chapter 6.0 The Science of Innate Immunity 6.1 critical regulator of human inflammatory disease 6.2 anatomic and physiologic barriers to pathogens - cancer causing viruses 6.3 centrally a limited number of critical receptors 6.4 the character of the inflammatory response 6.5 lack of ability to form memory 6.5 role in activating subsequent adaptive immune response Chapter 7.0 Immune Surveillance 7.1 history of concept (Ilya Mechnikov 1908 Nobel Prize) 7.2 evidence for immune surveillance today 7.3 cancer in the immunocompromised host Chapter 8.0 Cancer - Avoiding Immune Detection 8.1 cancer and the presence of immune resistance 8.2 concept for the development of tumor cell tolerance Chapter 9.0 Active Immunization Against Cancer and Cell-based Therapies 9.1 infusing in-vitro expanded Tumor Infiltrating Lymphocytes (TILs) 9.2 infusing dendritic cells pre-loaded with tumor specific oligopeptide antigens 9.3 B7 co-activating receptor 9.4 vaccines Chapter 10.0 The Three Major Clinical Components of Cancer Immunotherapy (modulating cell-mediated immune mechanisms) 10.1 the role of and application of check point blockade 10.2 the role and application of cell-based therapies including CAR-T cell therapies 10.3 antibodies (and vaccines); monoclonal antibodies and novel application of bi- or tri-specifics Chapter 11.0 The Clinical Application of Immunotherapeutics 11.1 in melanoma cancer 11.2 in breast cancer 11.3 in pancreatic cancer 11.4 in colon and rectum cancer 11.5 in prostate cancer 11.6 in leukemias and hematologic malignancies 11.7 in other malignancies Chapter 12.0 Cancer Immunotherapy in the Presence of COVID-19 12.1 immune response to coronavirus-2 infection 12.2 CD8+ T cell depression during chronic viral infection and cancer 12.3 checkpoint inhibitors in cancer patients with coronavirus infection 12.4 coronavirus depletion of CD4+ T cells
£999.99
Elsevier Science & Technology Diagnosis and Management of Hereditary Cancer
Book SynopsisTrade Review"Henson and Resta have compiled a thorough catalogue of clinically important cancer genes in a novel, accessible format that takes it to another level." --Jeffrey N. Weitzel, MD, Oncogenomicist for Precision PreventionTable of ContentsI. Genetics II. Genetic Testing III. Clinical Features IV. Tumors - Syndromes - Genes V. Classic Hereditary Cancer Syndromes
£999.99
Elsevier - Health Sciences Division Breast Cancer Multidisciplinary Pathways for
Book SynopsisTable of ContentsSection 1 Background Knowledge 1 Guiding Principles in Neurological Rehabilitation 2 Clinical Reasoning in Neurological Physiotherapy: Assessment and Treatment Principles 3 Common Impairments and the Impact on Activity 4 Observation and Analysis of Movement 5 Measurement Tools 6 Goal Setting in Rehabilitation Section 2 Management of Specific Conditions 7 Stroke 8 Traumatic Brain Injury 9 Spinal Cord Injury 10 Multiple Sclerosis 11 Parkinson's 12 Inherited Neurological Conditions 13 Motor Neurone Disease 14 Polyneuropathies 15 Neuromuscular Disorders 16 Functional Motor Disorders 17 Vestibular Rehabilitation Section 3 Specific Management 18 Respiratory Management 19 Self-Management 20 Neurorehabilitation Technologies 21 Falls and Their Management 22 Physical Activity and Exercise in Neurological Rehabilitation 23 Pain Management 24 Clinical Neuropsychology in Rehabilitation 25 Selected Topics in Physical Management for Neurological Conditions Appendix: Answers to Self-Assessment Questions Abbreviations Index
£999.99
Taylor & Francis Ltd Operative Surgery of the Colon Rectum and Anus
Book SynopsisThe sixth edition of Operative Surgery of the Colon, Rectum and Anus presents the state of the art in colorectal surgery. Edited by world renowned surgeons and with expert chapters from contributors in North America, Europe, and Australasia, the book is essential reading for the experienced surgeon established in colorectal practice as well as advanced trainees in general surgery. Each procedure is described in authoritative text beautifully complemented by high quality step-by-step color artwork and intraoperative photographs, enabling the reader to approach common and rare colorectal conditions with confidence.The book comprehensively covers surgery of the anus, rectum and colon in 87 chapters, grouped into nine sections for ease of reference (General Principles, Proctology, Stomas, Small Intestine, Colon, Rectum, Perineal Reconstruction, Rectal Prolapse and Surgery for Incontinence). The print edition is further enhanced by an accompanying VitalSource eBook, enablinTrade Review"…the editors have succeeded in their stated aim to produce a definitive contemporary textbook of operative colorectal surgery. I think a copy should be available in any hospital library where colorectal surgery is performed…"—Colorectal DiseaseTable of ContentsGeneral Principles. Preparation for colorectal surgery .Safety and positioning in the operating room. Access to abdominal cavity – open. Access to abdominal cavity – laparoscopic. Access to abdominal cavity – hand-assisted laparoscopic surgery. Single incision laparoscopic-assisted colectomy. Access to the abdominal cavity: natural orifice transluminal endoscopic surgery. Anastomotic technique – suture. Anastomotic technique – stapled. Specimen handling. Proctology. Office/outpatient set up. Proctosigmoidoscopy. Flexible endoscopy. Treatment of uncomplicated haemorrhoids. Excision of perianal thrombosis. Open hemorrhoidectomy. Closed hemorrhoidectomy. Stapled hemorrhoidopexy. Perianal sepsis. Anal fistula. Rectovaginal fistula repair. Anal fissure. Anoplasty. Perianal condyloma and anal intraepithelial neoplasia. Perianal skin and anal cancer Pilonidal disease. Stomas. Ileostomy. Colostomy. Stoma closure. Antegrade continence enema procedure in children. Antegrade continent enema procedure in adults. Small intestine. Small bowel resection. Meckel’s diverticulum. Malrotation. Intestinal stricturoplasty. Adhesiolysis. Colon. Appendicectomy – open. Appendicectomy – laparoscopic. Right colectomy – open. Right hemicolectomy – laparoscopic. Right hemicolectomy – hand-assisted laparoscopic surgery. Left colectomy – open. Left hemicolectomy – laparoscopic. Left hemicolectomy – hand-assisted laparoscopic surgery. Colectomy – complete mesocolic excision. Total colectomy – laparoscopic. Total colectomy – HALS. Hartmann’s procedure. Emergency colectomy. Colonic stenting. Rectum. Anterior resection of the rectum. Anterior resection – laparoscopic . Anterior resection – hand-assisted laparoscopic surgery. Anterior resection – robotic. Coloanal anastomosis with intersphincteric resection and colon J-pouch construction. Proctocolectomy for inflammatory bowel disease – open. Proctocolectomy for irritable bowel disease – laparoscopic. Continent ileostomy (Kock reservoir ileostomy). Restorative proctocolectomy with ileal reservoir .Abdominoperineal excision of the rectum and anus. Operative technique for pelvic exenteration. Pelvic exenteration: radical perineal approaches and sacrectomies. Lateral pelvic lymph node dissection in low rectal cancer. Transanal resection for rectal lesions. Transanal endoscopic microsurgery. Presacral resections – Kraske. Surgery for Hirschsprung’s disease. The APPEAR procedure. Vertical reduction rectoplasty for idiopathic megarectum. Perineal reconstruction. VRAM flap. Martius flap. Local advancement flaps. Rectal prolapse. Delorme operation. Perineal rectosigmoidectomy. Abdominal rectopexy – open. Abdominal rectopexy – laparoscopic. Laparoscopic ventral rectopexy. STARR. The EXPRESS procedure. Surgery for incontinence. Surgical repair of the anal sphincters following injury. Sacral nerve stimulation. Construction of an electrically stimulated gracilis neoanal sphincter. Artificial bowel sphincter.
£999.99
Little, Brown Book Group Pretty Sick The Beauty Guide for Women with
Book SynopsisThe ultimate resource to looking your best during and after cancer treatment, from a veteran beauty industry insider. Like many women who receive the shattering diagnosis of cancer, Caitlin Kiernan was concerned about her health and her future, but also about how the treatment would affect how she felt and looked - would she lose her hair? Would she lose her nails? How would she look after a double mastectomy?But unlike other women who battle cancer, Kiernan has spent her entire career as a beauty editor, beauty director (most recently for Life & Style Weekly), and now beauty producer. As someone who works in the public eye and in the fashion industry, Kiernan had to quickly learn how to look her best even when she was feeling her worst. So she called on her list of extensive contacts and beauty insiders - from hair professionals to top medical doctors (at institutions like Memorial Sloan Kettering and Mt Sinai Hospital) to style mavens and even celeTrade ReviewIndustry-shaking women like Caitlin Kiernan are rising to the challenge [of helping women with cancer feel confident]. In her book, Kiernan fills the adorably illustrated pages with bits and pieces of wisdom for those everyday moments - providing insightful, beauty-related advice for the kickass woman who has no intention of letting a disease like cancer get in the way of her all-around fire -- Erin Jahns * Byrdie *
£13.49
Taylor & Francis Ltd Understanding Cancer
Book SynopsisUnderstanding Cancer is a brand new undergraduate textbook for students without prior training in biology that integrates an introduction to cancer medicine with descriptions of the biological processes that go wrong to cause cancer's onset and progression. It also highlights the human side of cancer with stories of patients and loved ones touched by the disease, dealing with diagnosis, treatment, and the prospect of death as well as the broader societal aspects of cancer and its prevention. Key discoveries that have improved our understanding of cancer are presented in sidebars. In spite of this diversity, the book maintains precision and simplicity in describing what is and is not known about cancer, describing the strengths and limitations of current treatmentsTable of Contents1. Cancer and the Biology of Human Cells. 2. Cancer Detection, Diagnosis, and Prognosis. 3. The Organization of Normal Human Cells. 4. How Normal Cells Reproduce and Differentiate. 5. Factors that Promote the Cancerous Transformation of Cells. 6. Oncogenes and their Role in Cancerous Transformation. 7. Tumor Suppressors and their Roles in Resisting Carcinogenic Transformation. 8. Medical Treatment for Cancer. 9. The Immune System and its Relationship to Cancer. 10. A Perspective on "Cancer Futures". 11. Minimizing Cancer Risk. 12. Living with Cancer.
£131.34
Taylor & Francis Ltd Prostate Cancer
Book SynopsisWritten by over 250 of the world''s leading urologists and uro-oncologists from the USA, Canada, UK, Austria, Belgium, Finland, France, Germany, Ireland, Italy, the Netherlands and Singapore, who tackle prostate cancer on a daily basis, this comprehensive and fully up-to-date illustrated text reference covers the etiology, pathophysiology, diagnosis, management and treatment of early and advanced prostate cancer.Table of ContentsSection A. Introduction Section B. Pathology of Prostate Cancer Section C. Etiology of Prostate Cancer Section D. Molecular Mechanisms of Prostate Carcinogenesis Section E. Clinical Diagnosis and Staging of Prostate Cancer Section F. Treatment of Early Stage Prostate Cancer Section G. Treatment of Locally Advanced and Metastatic Prostate Cancer
£56.99
WW Norton & Co Saving Charlotte
Book SynopsisBest-selling author Pia de Jong’s vivid memoir about her daughter’s battle with leukaemia and the startling decision that led to her recovery.Trade Review"... her prose is vibrant and precise..." -- Times Literary Supplement
£19.31
Taylor & Francis Ltd Tumor Immunology Molecularly Defined Antigens and
Book SynopsisAn introductory overview of the immunology of cancer including therapeutic approaches, this book will be an invaluable source for clinicians, researchers and students of immunology and molecular biology.Table of ContentsIntroduction. Immune Recognition of Cancer-Tumor Antigens. Processing and Presentation of Antigen for the Activation of Lymphocytes. Cellular Recognition of Tumors by T and NK Cells. Humoral Recognition of Cancer. Immunotherapy of Cancer. Tumor Evasion of Immune System.
£115.00
Taylor & Francis Ltd Tumor Antigens Recognized by T Cells and
Book SynopsisRecent progress in fundamental tumor immunology has led to immunotherapy trials in patients with solid tumors and hematological malignancies. In the past, immunotherapy approaches were primarily based on enhancement of tumor immunity with cytokines and adjuvant therapy, without knowledge of relevant tumor antigens. The discovery of tumor antigens capable of eliciting immune responses has now resulted in the development of antigen-specific immunotherapy strategies. Vaccination with defined peptide epitopes, purified proteins, cell components, and whole cells expressing defined tumor antigens provides an opportunity to measure antigen-specific immune responses in vaccinated patients, and to correlate immunity with clinical outcome.Tumor Antigens Recognized by T Cells and Antibodies provides a comprehensive overview of the molecular nature of tumor antigens that can be recognized by antibodies, helper T lymphocytes and cytotoxic T lymphocytes. Novel strategies to enhance ineffectiTable of ContentsTumor Antigens Recognized by Antibodies. Human Tumor Antigens Recognized by Antibodies (SEREX). Antibodies to Tumor Oncoproteins in Cancer Patients. Antibody and CTL Responses to the NY-ESO Antigen. Tumor Antigens Recognized by CD4+ T Cells (predominantly TH1). Melanoma Antigens Recognized by CD4+ T Cells. Mouse Models in the Recognition of Tumor Antigens. Antigens of the MAGE Family Recognized by CD4+ T Cells. Tumor antigens Recognized by CD8 T Cells. Melanoma Antigens Recognized by CD8 T Cells. Squamous Cells and Adeno Cancer Antigens Recognized by T Cells. Heat/Shock Proteins and Tumor Antigens. The Wilms Tumor Antigens as CTL Target. Ex vivo and in situ Tetramer Analysis of CTL Responses to Tumors. Altered Peptide Ligands of Tumor T Cell Epitopes: Implications for More Effective Vaccine Therapy in Human Neoplasia.
£175.00
Taylor & Francis Ltd ESMO Handbook on Principles of Translational
Book SynopsisUsing state-of-the-art and evidence-based literature references and reviews, the authors present an overview of translational research that is both reliable and easily understood. The book begins with principles of normal cell biology and normal immunology. It examines tumor biology and basic tumor immunology. It then discusses limitless replicative potential, self-sufficiency in growth signals, insensitivity to anti-growth signals, and evading apoptosis. The book concludes with a chapter on angiogenesis, tissue invasion and metastasis, treatment, and evaluation of treatment.Trade Review"This book is featured in 18 short, and at the same time exhaustive, chapters whose aim, true to Jose Baselga's foreword, is to facilitate the understanding of the key areas of translational research. […] I am deeply convinced this handbook provides a rewarding and enjoyable reading, embodying a common, useful tool of discussion between the research and the clinical word." Marco A. Pierotti, ESMO NewsletterOctober-December 2007Table of ContentsPrinciples of Normal Cell Biology. Principles of Normal Immunology. Principles of Tumor Biology. Basic Tumor Immunology. Limitless Replicative Potential. Self-Sufficiency in Growth Signals. Insensitivity to Anti-Growth Signals. Evading Apoptosis. Angiogenesis. Tissue Invasion and Metastasis. Treatment. Treatment Evaluation
£31.99
Taylor & Francis Ltd Prognostic and Predictive Factors in Breast
Book SynopsisThis title reviews the key prognostic factors in breast cancer, discussing the methodologies involved in measuring and reporting. It also examines the roles of major predictive markers such as the steroid receptors, p53 and HER-2. Given the wealth of information in the medical literature on breast cancer, this volume is useful in that it focuses strictly on these factors. That focus makes this text extremely useful for oncologists and researchers who want to learn more about best practices in prognoses.Table of ContentsIntroduction / Overview. Role of the Pathologist in Assessing Prognostic Factors for Breast Cancer. Determination and Significance of Lymph Node Occult Metastasis in Breast Cancer. Prognostic Value of Proliferation and Apoptosis in Breast Cancer. The Role of Cell-Cell and Cell-Stromal Interactions in Predicting Breast Cancer Behavior. Detection of Minimal Residual Disease in Predicting Outcome in Breast Cancer. Allelic Imbalance / Microsatellite Instability in Breast Cancers and Blood Determining Breast Cancer Behavior. The Use of Steroid Receptors in Predicting Response to Hormonal Therapy. MAP Kinase Family Members and Endocrine Response and Survival in Breast Cancer. p53 and Breast Cancer. Assessment of HER-2 and its Value in Breast Cancer.
£999.99
Taylor & Francis Ltd Management Options in Breast Cancer
Book SynopsisManagement Options in Breast Cancer is the only comprehensive resource devoted to exploring the systematic approach to breast cancer diagnosis, surgery, and postoperative care. This guide is an ideal tool for oncologists, pathologists, radiologists, and gynecologists seeking alternative management options for breast cancer. In addition, trainees will find this text a valuable reference for learning the basic principles and clinical guidelines of the field.Key features in this stand-alone text: an international review of the management options in the field of breast cancer clinical practice case-based examples designed to aid in optimal clinician decision-making two chapters devoted to rarely-explored topics: male breast cancer and geriatric breast cancer Table of ContentsPreface. Acknowledgments. 1. Early Symptomatic Breast Cancer. Part I: Mastectomy. Case Study 1. Case Study 2. Case Study 3. Case Study 4. Case Study 5. Part II: Breast Conservation Therapy. Case Study 6. Case Study 7. Case Study 8. Case Study 9. Case Study 10. Case Study 11. 2. Screen-Detected Breast Cancer. Part I: Mastectomy. Case Study 12. Part II: Breast Conservation Therapy. Case Study 13. Case Study 14. Case Study 15. 3. Incidental Breast Cancer. Part I: Mastectomy. Case Study 16. Case Study 17. Case Study 18. Part II: Breast-Conservation Surgery. Case Study 19. 4. Ipsilateral Breast Tumor Recurrence. Case Study 20. 5. Diagnostic Excision Biopsy. Case Study 21. 6. Bilateral Breast Cancer. Case Study 22. Case Study 23. Case Study 24. 7. Inflammatory Breast Cancer. Case Study 25. Case Study 26. 8. Neoadjuvant Chemotherapy. Part I: Mastectomy Postchemotherapy Case Study 27. Case Studies. Part II: Breast Conservation Surgery Postchemotherapy. Case Study 28. 9. Primary Endocrine Therapy. Part I: Mastectomy after Primary Endocrine Therapy. Case Study 29. Case Study 30. Part II: Breast-Conservation Surgery after Primary Endocrine Therapy. Case Study 31. 10. Breast Cancer in the Elderly. Part I: Primary Endocrine Therapy. Case Study 32. Part II: Primary Radiotherapy. Case Study 33. 11: Pregnancy-Related Breast Cancer. Part I: First Trimester Pregnancy. Case Study 34. Part II: Third Trimester Pregnancy. Case Study 35. Case Study 36. 12. Prophylactic Mastectomy. Part I: Bilateral Prophylactic Mastectomy. Case Study 37. Part II: Contralateral Prophylactic Mastectomy. Case Study 38. 13. Lymphedema. Case Study 39. 14. Miscellaneous Conditions. Part I: Male Breast Cancer. Case Study 40. Case Study. 41. Part II: Paget’s Disease. Case Study 42. Part III: Phylloides Tumour. Case Study 43. Appendices. Index.
£999.99
Taylor & Francis Ltd Extranodal Lymphomas Pathology and Management
Book SynopsisLymphomas classically manifest themselves in the lymph nodes but can also present in other bodily tissues or systems; the organ where exactly they present may make a very great difference to the strategy that should be adopted for their management. This topic has only recently been consistently addressed as an issue on its own, apart from the rest of the lymphomas, and this text is the first to apply modern systems of classification, diagnosis and management. This text is essential reading for hematologic oncologists and hematopathologists.Table of ContentsPart 1: Conceptual basis 1 Challenging issues in the management of extranodal lymphomas 2 Historical prospects for the concept of primary extranodal lymphoma 3 Epidemiology of primary extranodal lymphoma 4 Infectious etiopathogenesis of primary extranodal lymphoma 5 Lymphocyte homing and immunology of extranodal lympoid tissue 6 Specific management problems posed by the primary extranodal presentations. Part I – staging and response evaluation 7 Specific management problems posed by the primary extranodal presentations. Part I – local control of localized disease Part 2: Pathobiology and clinicopathological correlations 8 Pathobiology and molecular basis of MALT lymphoma 9 Principles of the WHO classification with special reference to aggressive extranodal lymphomas 10 MALT lymphoma pathology, initial diagnosis, and post-treatment evaluation Part 3: Main Entities/Locations 11 Primary central nervous system lymphoma 12 Primary testicular lymphoma 13 Intravascular large B-cell lymphoma 14 Nasal natural killer/T-cell lymphoma 15 Primary breast lymphoma 16 Bone lymphoma 17 Lung lymphoma 18 Primary mediastinal (thymic) large B-cell lymphomas 19 MALT-type lymphoma of the orbit and ocular adnexae 20 Primary marginal zone lymphomas and other non-MALT marginal zone lymphomas 21 Gastrointestinal tract lymphomas 22 Cutaneous lymphomas 23 Primary extranodal head and neck lymphomas 24 Lymphoma of the liver 25 Extranodal lymphomas in patients with HIV infection 26 Primary effusion lymphoma 27 Rare sites 28 Extranodal Hodgkin’s lymphoma
£205.00
Taylor & Francis Ltd Principles and Practice of Head and Neck Surgery
Book SynopsisThis second edition of an award winning title has been thoroughly updated by a team of world leading head and neck surgeons, oncologists and allied healthcare professionals. Principles and Practice of Head & Neck Surgery and Oncology, 2nd edition is a comprehensive evidence-based account of the current scientific knowledge about head and neck tumors and their management. This book, with over 570 colour images, will provide a valuable source of knowledge and reference for all established specialists and trainees entrusted with the care of patients with head and neck tumors.Trade Review"This book, with over 570 colour images, will provide a valuable source of knowledge and reference for all established specialists and trainees entrusted with the care of patients with head and neck tumors." - Anticancer Research, November 2009"[An] improved, modern, well referenced and timely updated revision, which certainly will provide an excellent knowledge base for trainees across all related specialties involved in the MTD management of head and neck cancer patients." By Pr. Patrick J. Bradley, University of Nottingham, UK, in Oncology News, Jan/Feb 2010"The editors are to be congratulated on presenting in a most attractive way a range of complex material in this rapidly evolving field…the reviewer would strongly recommend its inclusion as a bench book for the multidisciplinary team"…. By John Lowry, In Annals of the Royal College of Surgeons of England, 2004."An outstanding book, one of the best in this complicated field, should be an addition to every budding head and neck surgeon’s collection. A must have!"…In The Internet Journal of Otorhinolaryngology, 2004."An outstanding contribution to the knowledge of head and neck cancer and I would highly recommend it, and it should be a standard text to any library. It should also be required for reading for Head and Neck Oncology trainees and surgeons"…by J P Jeannon, in ENT news, Jan/Feb 04"The Editors are internationally acknowledged in their field of head and neck oncology and this is reflected in their ability to produce a concise, yet wide ranging, text that is fully up-to-date and well referenced. It is indeed very difficult to find fault with this text and I’ve tried, but failed to do so. A concise, truly collaborative effort of high quality and excellent content"…by Kim Ah-See, in The Journal of Laryngology & Otology, 2004. "This book is a beautifully produced, highly illustrated and informative text, that should be on the shelves of every clinical unit that is involved in the management of patients with head and neck malignancy"… In British Journal of Oral and Maxillofacial Surgery, 2004"Each chapter includes practical clinical advice and treatment algorithms useful for those who do not regularly deal with patients who have cancer of the head and neck. This multidisciplinary approach makes the ‘Principles and Practice of Head and Neck Oncology’ an excellent reference for those who have head and neck oncology patients as part of their medical or surgical practice" … by R S Weber & K B Pytynia in British Journal of Cancer, 2004."As well as serving as a superb reference work for head and neck surgeons and clinical oncologists, Principles and Practice of Head and Neck Oncology will be of value to other participants in the multidisplinary of ENT"…by Andrew Swift, in Journal of the Royal Society of Medicine, November 2003."will provide a valuable source of knowledge and reference for all established specialists and trainees entrusted with the care of patients with head and neck tumors"Anticancer Research 29: 2009Table of ContentsPreface Foreword Section I – Basic Principles of Management 1. Head & Neck Malignancy: An Overview 2. Molecular Biology 3. Imaging of Head & Neck Tumours 4. Radiation Therapy for Head and Neck Cancer 5. Chemotherapy for Squamous Cell Carcinoma of the Head and Neck 6. Anaesthesia for Head and Neck Cancer 7. Nursing Care of Head & Neck Cancer Patients 8. Nutritional support of head and neck cancer patients 9. Dental Management of the Head & Neck Patient 10. Palliation of advanced head and neck cancer Section II – Tumour sites and specific tumours 11. Tumours of the Oral Cavity 12. Tumours of the oropharynx 13. Tumours of the Hypopharynx 14. Tumours of the Larynx 15. Management of the Neck 16. Tumours of the Upper Jaw and Anterior Skull Base 17. Juvenile Agiofibroma 18. Tumours of the Nasopharynx 19. Tumours of the Parapharyngeal Space 20. Salivary Gland Neoplasms 21. Management of Tumours of the Temporal Bone 22. Management of thyroid cancer 23. Tumours of the Parathyroid Glands 24. Sarcomas of the Head and Neck 25. Non-melanoma skin cancer 26. Cutaneous Melanoma of the Head and Neck Section III – Complications, Reconstruction, Rehabilitation & Future Developments 27. Complications in Head and Neck Cancer Surgery 28. Principles of Head and Neck Reconstruction 29. Reconstruction of the oral cavity and oropharynx 30. Reconstruction of the Ear 31. Principles of Nasal Reconstruction 32. Functional voice restoration after total laryngectomy 33. Future Developments in Head and Neck Cancer Therapy
£427.50
Taylor & Francis Ltd Treatment and Management of Bladder Cancer
Book SynopsisDrawing on the expertise of an international community of experts in the field, this book provides the reader with all aspects of diagnosis and treatment pertaining to bladder cancer. The book also includes a cd-rom containing the figures and legends from each chapter in a user-friendly format, in order to further aid the reader.Table of ContentsSection 1 Treatment 1. Transurethral resection of bladder tumors 2. Perioperative instillation of chemotherapeutic drugs 3. The Role of Intravesical Chemotherapy in the Treatment of Bladder Cancer 4. Intravesical Chemotherapy of Superficial Bladder Cancer: Optimization and Novel Agents 5. Intravesical Immunotherapy: BCG 6. G3T1 bladder carcinoma 7. What to do When BCG Fails Section 2 T2-4 8. Selection and Peri-operative Management of Patients Undergoing Radical Cystectomy and Urinary Reconstruction 9. Radical Cystectomy: Technique and Outcomes 10. Cystectomy in the Female 11. Nerve Sparing: Radical Cystectomy 12. Laparoscopic Radical Cystectomy and Urinary Diversion 13. Role of Extended Lymphadenectomy 14. Management of the urethra in the cystectomy patient 15. Role of radical cystectomy in patients with unresectable and/or loco-regionally metastatic bladder cancer Section 3 Primary Bladder Sparing Therapy 16. Radical TURBT 17. Partial Cystectomy 18. Optimal Radiotherapy for Bladder Cancer 19. Trimodality Therapy in the Management of Muscle Invasive Bladder Cancer: A Selective Organ-preserving Approach Section 4 Urinary Tract Reconstruction 20. Orthotopic Neobladder 21. Continent Cutaneous Diversion 22. Noncontinent urinary diversion Section 5 Treatment of Regionally Advanced and Metastatic Bladder Cancer 23. Neo-adjuvant Chemotherapy in the treatment of muscle-invasive bladder cancer 24. Adjuvant Chemotherapy for invasive Bladder Cancer 25. Treatment of Metastatic Cancer
£123.50
Taylor & Francis Ltd Hepatocellular Carcinoma A Practical Approach
Book SynopsisAn essential resource for gastroenterologists, hepatologists, liver surgeons, hepatobiliary surgeons, oncologists, and all those working in the field of hepatocellular carcinoma (HCC), Hepatocellular Carcinoma: A Practical Approach covers the updates and recent developments on the diagnosis, screening, and comprehensive medical and surgical management of HCC.This one-of-a-kind textbook explores all aspects of the disease using a practical, evidence-based approach, and provides step-by-step treatment guidelines that are applicable to all clinical scenarios.Highlights in the text include: screening and surveillance methods to aid in the prevention of HCC imaging technologies for accurate diagnosis, including ultrasound and PET treatment modalities for HCC, such as local ablation therapy, chemoembolization, chemotherapy, and liver resection and transplantation a discussion on novel therapies and fuTrade Review This volume covers comprehensively recent developments on the diagnosis, screening and medical and surgical of HCC, and is essential reading for gastroenterologists, hepatologists, liver surgeons, hepatobiliary surgeons, oncologists and other working in the field of HCC." - Anticancer research, April 2010 Table of Contents Epidemiology, Pathogenesis, Surveillance, and Prevention: Epidemiology of the Hepatocellular Carcinoma. Molecular Pathogenesis. HCC Screening and Surveillance. Prevention of Hepatocellular Carcinoma. Diagnosis: Tumor Markers and Molecular Biology. Imaging of Hepatocellular Carcinoma. Staging. Management: Local Ablation Therapy. Chemotherapy and Novel Systemic Therapies. Chemoembolization, Radioembolization, and Other Novel Intra-arterial Therapies. Liver Resection. Liver Transplantation as Treatment for HCC.
£170.00
Penguin Putnam Inc Anticancer A New Way of Life
Book SynopsisThe revolutionary, New York Times bestselling guide to the powerful lifestyle changes that fight and prevent cancer—an integrative approach based on the latest scientific research “A common-sense blueprint for healthy living.” —Chicago Tribune “Resonating with cancer support communities and recommended nationwide.” —Los Angeles Times “Life affirming . . . filled with practical advice.” —The Seattle Times David Servan-Schreiber was a rising neuroscientist with his own brain imaging laboratory when, in the middle of an equipment test, he discovered a tumor the size of a walnut in his own brain. Forced to confront what medicine knows about cancer, and all that we still do not know, Servan-Schreiber marshaled his will to live and set out to understand the complex inner workings o
£16.15
John Wiley & Sons Inc Cervical Cancer
Book SynopsisThis is a comprehensive guide to cervical cancer for nurses. It is a practically-based text for clinical nurses who wish to consolidate and update their knowledge of cervical cancer. It is concise, containing comprehensive information for general practice together with useful references to facilitate more in-depth study. Thus it provides an invaluable resource for both the registered nurse with a general interest in cervical cancer and for the nurse specialist working in primary health, gynaecology, oncology and palliative care. As well as containing the essential chapters about the pathophysiology and treatment of cervical abnormalities and cervical cancer, the book also addresses specific nursing issues such as sexuality, fertility, and symptom control. Moreover it examines the bigger, global picture of the disease. Full appreciation of global impact of cervical cancer on women involves an appreciation of the social, political and public health aspects of the disease not only inTrade Review“This is a high quality book, both in content and thoroughness.” (Doody's Reviews, May 2009)Table of ContentsAcknowledgements. 1. Dysplasia, HPV and cervical cancer. 2. Pre-invasive disease, colposcopy and adenocarcinoma. 3. Surgery. 4. Radiotherapy. 5. Chemotherapy. 6. Psychological and Social Aspects of Cervical Cancer. 7. Fertility and menopause. 8. Cervical screening. 9. Cervical cancer in developing countries. 10. Cervical cancer vaccines.
£45.55
John Wiley and Sons Ltd Gynecologic Oncology
Book SynopsisThis is the only reference and textbook of its kind to cover perioperative and supportive care in gynecologic oncology within the framework of evidence-based medicine.Table of ContentsForeword to the Second Edition ix Contributors xi Part One General Principles 1. Introduction 1 Steven A. Vasilev and Scott E. Lentz 2. Evidence-Based Medicine and Decision Support 11 Steven A. Vasilev 3. Vascular Access and Other Invasive Procedures 43 Paul Koonings and Scott E. Lentz 4. Fluids, Electrolytes, and Nutrition 69 Howard Silberman and Matthew Powers Part Two Perioperative Management of Gynecologic Surgery 5. Preoperative Evaluation 145 Devansu Tewari 6. Postoperative Surveillance and Perioperative Prophylaxis 161 Harriet O. Smith and Lejla Delic 7. Perioperative Infections: Prevention and Therapeutic Options 235 Amy Stenson 8. Intraoperative and Perioperative Considerations in Laparoscopy 261 Steven A. Vasilev and Scott E. Lentz Part Three Oncologic Perioperative Decision Making 9. Cervical Carcinoma 299 Fidel A. Valea 10. Endometrial Cancer 329 R. Wendel Naumann 11. Pelvic Masses and Ovarian Carcinoma 361 Margarett C. Ellison 12. Molar Gestation 377 Allison E. Axtell and Steven A. Vasilev 13. Perioperative Issues in the Management of Vulvar Cancer 389 Kathryn F. McGonigle and Maliaka W. Amneus Part Four Complimentary Medicine/Supportive Care 14. Perioperative Psychosocial Considerations 419 Judith McKay and Steven A. Vasilev 15. Pain Management in Gynecologic Oncology 443 Laszlo Z. Galffy and Clayton A. Varga 16. Fertility Preservation in the Gynecologic Cancer Patient 469 Nicole Fleming 17. Perioperative Herbal and Supplement Use 487 Alexander Vasilev and Steven Vasilev 18. End-of-Life Decision Making 509 Scott E. Lentz Index 539
£139.60
John Wiley and Sons Ltd The Genetic Basis of Haematological Cancers
Book SynopsisWritten by a team of international experts, this book provides an authoritative overview and practical guide to the molecular biology and genetic basis of haematologic cancers including leukemia.Table of ContentsList of contributors xi Preface xiii 1 The myelodysplastic syndromes 1 Cristina Mecucci, Valeria Di Battista and Valeria Nofrini Introduction 1 Predisposing conditions 2 Familial platelet disorder with propensity to myeloid malignancy (FPD/AML) 2 Severe congenital neutropenia (SCN) 5 Poikiloderma with neutropenia 6 Familial MDS/AML 6 Shwachman–Diamond syndrome (SDS) 7 Dyskeratosis congenita (DKC) and telomere syndromes 8 Fanconi anaemia (FA) 11 Down syndrome 12 Cytogenetics 12 Loss of Y chromosome (–Y) and del(11q) 13 Del(20q) 15 idic(X)(q13) 15 Del(17)(p13)/i(17q) 15 Del(12p) 16 Trisomy 8 16 Rare trisomies: +6, +13, +14, +15, +16, +19, +21 16 Monosomy 7 and del(7q) 17 Rare monosomies 19 Unbalanced translocations involving 1q 19 t(17;18)(p10;q10) 20 Rare or sporadic balanced translocations 20 Complex karyotypes 22 Chromosome 5q deletions 23 Somatic mutations 31 Oncogenes and tumour suppressor genes 31 Mutations of genes involved in epigenetic modulation 39 Mutations of genes involved in the spliceosome machinery 45 Rare gene mutations in myelodysplastic syndromes 48 Epigenetics 49 DNA methylation 50 Histone modifications 52 RNA 53 Conclusion 54 References 54 2 Molecular genetics of the myeloproliferative neoplasms 80 Philip A. Beer Introduction 80 Overview of the different types of mutation found in MPN patients 80 Acquired mutations in cytokine signalling pathways 82 Acquired mutations in pathways controlling transcriptional regulation 84 Acquired mutations associated with transformation to advanced-phase disease 87 Inherited predisposition to clonal MPNs 87 Inherited non-clonal disorders that phenocopy distinct MPNs 87 Polycythaemia vera (PV), essential thrombocythaemia (ET) and primary myelofibrosis (PMF) 88 Acquired mutations in cytokine signalling pathways (Table 2.3) 89 Acquired mutations in pathways controlling transcriptional regulation (Table 2.4) 95 Acquired mutations associated with progression to advanced and blastic-phase disease 101 Inherited predisposition to clonal MPNs 103 Inherited non-clonal disorders that phenocopy distinct MPNs 104 Principles and clinical utility of laboratory testing 107 Chronic eosinophilic leukaemia 109 Acquired mutations in cytokine signalling pathways 109 Acquired mutations in pathways controlling transcriptional regulation 113 Acquired mutations associated with progression to advanced and blastic-phase disease 113 Inherited predisposition to clonal MPNs 113 Inherited non-clonal disorders that phenocopy distinct MPNs 114 Principles and clinical utility of laboratory testing 114 Neoplastic mast cell disease 115 Acquired mutations in cytokine signalling pathways 116 Acquired mutations in pathways controlling transcriptional regulation 118 Acquired mutations associated with progression to advanced and blastic-phase disease 118 Inherited predisposition to clonal MPNs 119 Inherited non-clonal disorders that phenocopy distinct MPNs 119 Principles and clinical utility of laboratory testing 120 References 121 3 Acute myeloid leukaemia 133 Matthew L. Smith and Thomas McKerrell Introduction 133 AML classification 134 Cytogenetic aberrations 135 Fusion genes arising from structural rearrangements 135 Monosomies 148 Complex and monosomal karyotypes 148 Trisomies 148 Double minute chromosomes 151 Normal karyotype – is it really normal? 151 Altered gene expression 152 EVI1 152 BAALC 153 MN1 153 ERG 154 SET 154 BRE 154 WT1 154 miRNA genes 154 Diagnosis and classification of AML 155 Current risk stratification of AML patients: European LeukemiaNet (ELN) guidelines 156 Therapeutic regimens in AML 158 Management of younger adults aged 18–60 years 159 Older AML patients (aged >60 years) 159 Novel agents 160 Monitoring response to therapy (MRD) 160 The genomics of AML 161 Clonal evolution of AML 161 Established recurrent mutations in AML 163 Novel recurrent mutations in AML 173 Emerging concepts and future directions 179 Age-related clonal haematopoiesis (ARCH) 179 Application of genomic technologies to the diagnosis of AML 179 Conclusion 181 Mini-glossary 183 References 184 4 Molecular genetics of paediatric acute myeloid leukaemia 203 Marry van den Heuvel-Eibrink, Jasmijn D.E. de Rooij and Christian Michel Zwaan Clinical introduction 203 Epidemiology of AML 203 Diagnostic approach 204 Treatment and outcome 205 Relevant molecular and genetic aberrations in paediatric AML 206 Type I/II aberrations and their non-random associations 206 Relevance of type I/II aberrations for outcome and stratification of paediatric AML treatment 209 Epigenetic modifiers and hydroxymethylation pathway mutations 212 Further strategies 213 Further genomic approaches to unravelling the biology of paediatric AML 213 Molecularly targeted therapy 214 Conclusion 215 References 215 5 Acute lymphoblastic leukaemia 223 Anna Andersson, Anthony V. Moorman, Christine J. Harrison and Charles Mullighan Introduction 223 Chromosomal aberrations in BCP-ALL 224 High hyperdiploidy 227 t(12;21)(p13;q22)/ETV6-RUNX1 232 t(1;19)(q23;p13)/TCF3-PBX1 233 t(17;19)(q22;p13)/TCF3-HLF 234 Hypodiploidy 234 11q23/KMT2A (MLL) gene rearrangements 236 t(9;22)(q34;q11.1)/BCR-ABL1 237 Intrachromosomal amplification of chromosome 21 (iAMP21) 238 Complex karyotype 239 Submicroscopic genetic alterations in BCP-ALL 240 Alteration of transcription factors in BCP-ALL 241 CRLF2 rearrangements and Janus kinase mutations in ALL 242 BCR-ABL1-like or Ph-like ALL 243 ERG-altered ALL 245 Genetic rearrangements in T-lineage ALL 245 TAL1/LMO2 rearranged T-ALL 247 TLX1/TLX3 rearranged T-ALL 248 Early T-cell precursor ALL 249 Other T-ALL genetic subtypes: MLL rearranged and PICALM-MLLT10 250 Relapsed ALL 251 Future directions 252 References 252 6 The genetics of mature B-cell malignancies 265 Jonathan C. Strefford, Jude Fitzgibbon, Matthew J.J. Rose-Zerilli and Csaba Bödör Introduction 265 Chronic lymphocytic leukaemia 266 Immunoglobulin heavy-chain variable region gene mutational status 267 Chromosomal banding and interphase molecular cytogenetics 268 Copy number alterations 269 Deletions of 13q14 269 Trisomy 12 272 Deletions of 11q24 and mutations of ATM 273 Deletions of 17p13 and mutations of TP53 275 Other copy number alterations in CLL 276 Genome complexity and chromothripsis 277 Novel mutations in patients with CLL 279 NOTCH1 280 SF3B1 281 Other genes 282 Novel genetic mutations in clinical practice 282 Germinal centre lymphomas 284 Follicular lymphoma 286 Diffuse large B-cell lymphoma 293 Conclusions and future perspectives 296 Acknowledgements 299 References 299 7 The genetics of chronic myelogenous leukaemia 312Philippa C. May, Jamshid S. Khorashad, Mary Alikian, Danilo Perrotti and Alistair G. Reid Introduction 312 Clinical features 313 The structure and physiological function of BCR and ABL1 316 The structure of the BCR-ABL1 fusion gene 317 Mechanisms of BCR-ABL1-induced oncogenesis 319 Potential mechanisms underlying the genesis of CML 320 CML blast crisis transformation 321 Tyrosine kinase inhibitor (TKI) therapy 325 The genetic basis of TKI resistance 326 Novel therapeutic approaches 330 Genetics in patient management 332 Cytogenetic and molecular cytogenetic monitoring 332 Quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) 334 BCR-ABL1 mutation analysis 337 Conclusion 338 References 339 Index 359
£108.86
University of California Press Malignant
Book SynopsisCancer can kill: this fact makes it concrete. Still, it's a devious knave. Nearly every American will experience it up-close and all too personally, wondering why the billions of research dollars thrown at the word haven't exterminated it from the English language. This title deals with this cancer.Trade Review"Brilliant." -- Barbara Kiser Nature "A whip-smart read." -- Becky Lang Discover "A dark journey into cancer as it is understood, diagnosed and treated in America today." Kirkus "The book effortlessly combines the author's roles as a first-person participant in cancer diagnosis and an anthropological authority on why we Americans tolerate high rates of cancer." http://www.publicbooks.org/nonfiction/cancers-poison-gift Public Books "Malignant is a wonderful book... In this candid and critical analysis, [Jain]... eloquently captures the ambiguity and uncertainty that undergird every aspect of cancer." Journal of Anthropological ResearchTable of ContentsIntroduction: We Just Don't Know It Yet 1. Living in Prognosis: The Firing Squad of Statistics 2. Poker Face: Gaming a Lifespan 3. Cancer Butch: Trip Up the Fast Lane 4. Lost Chance: Medical Mistakes 5. The Mortality Effect: The Future in Cancer Trials 6. Inconceivable: Where IVF Goes Bad 7. Can Sir: What Screening Doesn't Do 8. Fallout: Minuets in the Key of Fear 9. Rubble: Bakelite Bodies Conclusion: Shameless Acknowledgments Notes Index
£999.99
Human Kinetics Publishers ACSMs Guide to Exercise and Cancer Survivorship
Book SynopsisACSM’s Guide to Exercise and Cancer Survivorship provides tools for offering safe exercise programs to help cancer survivors improve their health, take proactive steps toward preventing recurrences, and enhance their quality of life. Trade Review "Concise chapters cover descriptions of cancer to understanding how it doesn't need to be a limiting factor in exercise participation. The book does an excellent job of providing real-life examples and demonstrating how the recommendations can be implemented in everyday practice." --Doody’s Book Review, 5-star review Table of ContentsChapter 1. Diagnosis and Treatment of Cancer Larissa A. Korde, MD, MPH Cancer Incidence and Survival Cancer Biology Cancer Staging Cancer Screening and Diagnosis Cancer Recurrence Warning Signs Summary References Chapter 2. Side Effects and Persistent Effects of Cancer Surgery and Treatment Tara Sanft, MD, and Melinda L. Irwin, PhD, MPH Side Effects of Cancer Surgery and Treatment Recurrence, New Primaries, and Second Cancers Summary References Chapter 3. Lifestyle Factors Associated With Cancer Incidence, Recurrence, and Survival Heather K. Neilson, MSc, and Christine M. Friedenreich, PhD Effect of Body Weight Effect of Exercise Effect of Diet Summary References Chapter 4. Benefits of Physical Activity After a Cancer Diagnosis Kristin L. Campbell, BSc PT, PhD Physiological Effects of Exercise Training Psychological Benefits of Exercise Training Cancer-Specific Exercise Issues by Body System Effects of Cancer Medications or Treatments on Designing an Exercise Program Summary References Chapter 5. Cardiorespiratory Fitness Testing in Clients Diagnosed With Cancer Lee W. Jones, PhD, and Claudio Battaglini, PhD Administration of Cardiorespiratory Fitness Testing Exercise Testing Safety Summary References Chapter 6. Exercise Prescription and Programming Adaptations: Based on Surgery, Treatment, and Side Effects Kathryn Schmitz, PhD, MPH Health Promotion and Risk of Disease Reduction Exercise Prescription Alterations to Address Individual Needs Benefits and Risks of Exercise and Exercise Training Exercise Prescription Individualization Acute and Chronic Adverse Effects of Treatment Setting Goals Sample Exercise Prescriptions Summary References Chapter 7. Nutrition and Weight Management Stephanie Martch, MS, RD, LD, and Wendy Demark-Wahnefried, PhD, RD Diet in Cancer Prevention, Control, and Overall Health Weight Status and Body Composition Weight and Height Assessment Energy Consumption and Cancer Diet Composition and Nutrition Status Complementary Alternative Medicine and Functional Foods Dietary Supplements Alcohol Summary References Chapter 8. Health Behavior Change Counseling Karen Basen-Engquist, PhD, MPH; Heidi Perkins, PhD; and Daniel C. Hughes, PhD Effect of Cancer on Readiness to Exercise Theory-Based Methods and Exercise Translating Theory Into Practice Summary References Chapter 9. Safety, Injury Prevention, and Emergency Procedures Anna L. Schwartz, PhD, FNP, FAAN Cancer-Specific Safety Considerations Emergency Procedures Documentation Summary References Chapter 10. Program Administration Carole M. Schneider, PhD Designing a Cancer Rehabilitation Program Cancer Rehabilitation Programs and Settings Program Description and Operations Policies and Procedures Legal Issues and Documentation Reimbursement Concerns Community-Based Support Summary References
£58.90
Hachette Books The Meals to Heal Cookbook 150 Easy Nutritionally
Book SynopsisThe founder of savour Health (Meals to Heal) teams up with a specialist in oncology nutrition to offer 150 nutritionally balanced, easy, delicious recipes created with an eye toward the special needs of cancer patients.Trade ReviewPraise for The Meals to Heal Cookbook "Susan Bratton's wonderful cookbook is what every cancer patient needs--nourishing recipes to help them maintain their nutrition plus valuable information on how to customize those recipes to help cope with the challenging side effects of cancer treatments. And just maybe the benefits of this healthful way of eating can help everyone involved--both the patients and their families!"--Ina Garten, Barefoot Contessa cookbooks & television "If you, or your loved one, is undergoing treatment for cancer, The Meals to Heal Cookbook is a must. These delicious and nutritious recipes have been developed specifically for people in cancer treatment and take into account taste changes, appetite issues, and other issues that go along with treatment, and the dietitian authors are true experts in this field. I will most definitely be recommending this cookbook to my patients."--Lise Alschuler, ND, FABNO, coauthor, Definitive Guide to Cancer and Definitive Guide to Thriving After Cancer Myrtle Beach Sun News, 4/5/16 The organization of the recipes demonstrates the brilliance of the book and the authors' commitment to making it a useful tool. The recipes are set out in a standard way, by breakfast, lunch bowls entrees and the like. However, it is the two recipe indices that make the book really useful, listing the recipes by side effects and by symptoms...This is definitely a book to consider as a gift for anyone who has cancer, is recovering from cancer, or who is caring for someone suffering from this disease. Gratitude Gourmet, 4/18/16 The Meals to Heal Cookbook shares healthy, easy to prepare recipes that not only taste delicious but also mitigate the many side effects of cancer treatment...[It] is a go-to resource addressing all of the major food, cooking, and nutrition questions asked by patients and caregivers in a straightforward, accessible, and supportive manner. TheNest.com, 5/9/16 "[The] nutrient-packed recipes [are] perfect for those looking to regain control of their bodies and boost their overall health. Designed for those suffering from chemotherapy or radiation treatments, this cookbook provides easy-to-cook recipes for those experiencing some of cancer's harsh side effects. We were so inspired by the detail put into this cookbook...Whether you or someone you know is fighting the big C, or you just want access to simple, yet super wholesome recipes, The Meals To Heal Cookbook is for you. Sand and Succotash, 5/23/16 If you are on a cancer treatment path that includes chemo, then this is the perfect book to have in the kitchen...real world, wholesome recipes that provide nutrients making you stronger --and presented in a way that tackles your side effects and manages your symptoms. Highly recommended read. Atlanta Journal Constitution, 5/25/16 "This book shares healthy, easy to prepare recipes that not only taste delicious but also mitigate the many side effects of cancer treatment. Recipes are organized by meal as well as by side effect, allowing you to easily find meals suited to your particular health needs."
£14.24
Taylor & Francis Ltd The Physics of Modern Brachytherapy for Oncology
Book SynopsisBrachytherapy has become the modality of choice for several cancer localizations, minimizing the possibility of unacceptable risks for healthy tissues and providing a more cost-effective and convenient treatment for patients. Written by leading experts in the physics, development, and implementation of brachytherapy, The Physics of Modern Brachytherapy for Oncology discusses the subject in detail, covering its definition, the basic physics of radiation interaction with matter, radionuclides, sources and source production, calibration and dosimetry protocols as well as experimental dosimetry methods appropriate for practical use. Logically organized, the book begins with basic information, including quantities and units, followed by fundamental atomic and nuclear physics. It also provides the historical background of brachytherapy physics. The next several chapters discuss the radionuclides used in brachytherapy, reflecting upon past (radium), present (iridium or cobalt), and fuTrade Review"Detailing the physics behind brachytherapy treatment, this book is essential reading for researchers, practicing radiation oncologists, and medical physicists who want to keep abreast of the developments in this changing field as well as for postgraduate students in medical physics." –In Anticancer Research, Nov-Dec 2008, Vol. 28, No. 6BTable of ContentsThe Early History of Brachytherapy Physics. Radiation Quantities and Units. Atoms, Nuclei, Elementary Particles, and Radiations. Interaction Properties of Photons and Electrons. Brachytherapy Radionuclides and Their Properties. Production and Construction of Sealed Sources. Source Specification and Source Calibration. Source Dosimetry. Monte Carlo-Based Source Dosimetry. Experimental Dosimetry. Appendix 1: Data Table of the Isotopes. Appendix 2: Unit Conversion Factors and Physical Constants. Appendix 3: TG-43 Tables for Brachytherapy Sources. Appendix 4 Dose Rate Tables for Brachytherapy Sources. Index.
£999.99
University of British Columbia Press Health Advocacy Inc.
Book SynopsisIn this unsettling analysis of the breast cancer movement in Canada, health activist, scholar, award-winning journalist, and cancer survivor Sharon Batt investigates the changing relationship between patient advocacy groups and the pharmaceutical industry, as well as the contentious role of pharma funding.Trade Review[Health Advocacy Inc.] expands the conversation into new terrain, exploring how industry infiltrates patient advocacy groups employing the same tools that have been so successful with doctors… -- Anne Kingston * Literary Review of Canada *Batt`s scholarly approach allows opposing voices ... [her] goal is to start a conversation and encourage discussion. She readily achieves this effect, and any cancer charity currently facing a funding dilemma would be well served by her book. -- Isabel Lokody * Lancet Oncology *Health Advocacy Inc. occasionally feels like a Russian novel. It has plot twists and dissidents whose tactics and rebellions against drug companies are nothing short of heroic. Yet Batt eschews sensational tropes about the evils of big pharma in favour of interviews and archives describing the gradual demise of the breast cancer movement. -- Deborah Ostrovsky * Herizons *Batt makes a powerful case ... To this reviewer’s knowledge, this is the only study tracking the process of neoliberal reform and its cumulative impact on the same groups within civil society over such a long time frame and is ground breaking for that reason alone. -- Nick Acheson, University of Dublin Trinity College * Voluntary Sector Review *[Batt’s] superb new book is a deep scholarly account of the way that pharmaceutical funding has warped the patient advocacy movement into a tool for medical capitalism ... Few writers are better placed to document this story ... Would-be rebels and reformers should take to heart the cautionary lessons of Health Advocacy, Inc. -- Carl Elliott * Hastings Center Report *Batt’s revelations about the relationship between patient advocacy groups and the pharmaceutical industry are vital and disturbing. -- Lisa Cumming * Maisonneuve *In sum, Batt’s is a terrific book, a focused study of a policy area that has many lessons for all concerned with effective democratic policy making and the consequences of public-private partnerships and donor influence. -- Peregrine Schwartz-Shea, University of Utah * Journal of Empirical Research on Human Research Ethics *Health Advocacy Inc. is an extremely stimulating and timely book benefitting from the author’s scholarly skills, but also from her particular standpoint as a breast cancer activist. -- Grazia De Michele, doctoral researcher in history at the University of Genoa * Somatosphere *Batt has written a compassionate account of the debates among breast cancer activists in Canada and internationally about whether to accept money from the pharmaceutical industry … Now more than ever we need advocates who put drug safety, effectiveness and affordability above the interests of pharma. -- Colleen Fuller, cofounder of Pharma Watch Canada * Alberta Views *[Health Advocacy, Inc.] is not an easy read, but it should be devoured by anyone, from any nation, who wants to put together a similarly formidable argument for transparent and genuine discussion about what we should – indeed, must – do differently to prevent and treat human suffering and disease. -- Nancy MP King, Wake Forest University * Indian Journal of Medical Ethics Online *What makes the book stand out from the rest of the vast literature on these dynamics is the wealth of personal vignettes and in-depth case studies… Academics, funders, policy researchers and campaigners of all political stripes will find a lot to like, learn and think about in this meticulously researched and well-written book. -- Till Bruckner, founder of TranspariMED and advocacy manager for Transparify * On Think Tanks *To Batt’s credit, she never falls into the partisan trap of framing the issue as a moralistic struggle of good versus evil. While she stakes out a strong position, she treats the topic with the nuance it deserves. Drawing on a wealth of ethnographic material, she chronicles how decent people and committed organisations struggled to support and represent breast cancer patients over many years, despite financial constraints and funder attempts at co-optation. -- Till Bruckner * The HealthWatch Newsletter *Table of ContentsPrefaceIntroduction: The Secret War among Patient Groups Part 1: Canada’s Health Care System Transformed – Neoliberalism and the Erosion of the Welfare State1 Canada’s Health Policy Landscape2 Health Advocacy Organizations in Canada Part 2: From Grassroots to Contestation to Partnership – The Breast Cancer Movement and Big Pharma 3 Beginnings of the Breast Cancer Movement 4 Advocacy Redefined 5 The Movement Fractures over Pharma Funding6 Pharma Funding as the New Norm7 Advocacy Groups and the Continuing Struggle over the Pharma-Funding Question Conclusion: The Fight for Medicine’s SoulAppendix: Organizations and Their MembersNotesIndex
£25.19
Taylor & Francis Inc Understanding Cancer
Book SynopsisUnderstanding Cancer is a brand new undergraduate textbook for students without prior training in biology that integrates an introduction to cancer medicine with descriptions of the biological processes that go wrong to cause cancer's onset and progression. It also highlights the human side of cancer with stories of patients and loved ones touched by the disease, dealing with diagnosis, treatment, and the prospect of death as well as the broader societal aspects of cancer and its prevention. Key discoveries that have improved our understanding of cancer are presented in sidebars. In spite of this diversity, the book maintains precision and simplicity in describing what is and is not known about cancer, describing the strengths and limitations of current treatmentsTable of Contents1. Cancer and the Biology of Human Cells. 2. Cancer Detection, Diagnosis, and Prognosis. 3. The Organization of Normal Human Cells. 4. How Normal Cells Reproduce and Differentiate. 5. Factors that Promote the Cancerous Transformation of Cells. 6. Oncogenes and their Role in Cancerous Transformation. 7. Tumor Suppressors and their Roles in Resisting Carcinogenic Transformation. 8. Medical Treatment for Cancer. 9. The Immune System and its Relationship to Cancer. 10. A Perspective on "Cancer Futures". 11. Minimizing Cancer Risk. 12. Living with Cancer.
£48.99
Fordham University Press Called Back My Reply to Cancer My Return to Life
Book SynopsisTable of ContentsChapter 1 Diagnosis: news Chapter2 Surgery: measure Chapter 3 Chemotherapy: feelings Chapter4 Radiation: story coda Called Back: the voyage out Afterword to the 2021 Edition
£16.14
Taylor & Francis Inc Genetic Toxicology and Cancer Risk Assessment
Book SynopsisPresents state-of-the-art regulatory cancer risk assessment models including a biologically based model for two-hit carcinogenesis and cell proliferation!This book comprehensively reviews the various roles of genetic toxicology in human cancer risk assessment conducted by United States and worldwide regulatory agencies-discussing hazard identification, dose-response relationships, exposure assessment, and current practices of risk characterization.Examines predictive values of mutagenicity tests, mechanisms of carcinogenesis, and conventional genotoxicity tests required by the International Conference on Harmonization and the Organization for Economic Cooperation and Development/Environmental Protection Agency guidelines!Comprised of contributions from prominent experts and risk assessors and including nearly 1200 references to facilitate further study, Genetic Toxicology and Cancer Risk Assessmentreviews contemporary human cancer genetics as relatedTrade Review "…engaging and informative….…a useful contribution to the field of genetic toxicology."-Doody"…well-detailed….…a great reference material. "-Australian Journal of Medical Science"…offers the reader an authoritative, practical insight."-Cancer Forum Table of ContentsHuman Cancer Genetics Jason W. Barlow and David Malkin Genetic Toxicity Tests for Predicting Carcinogenicity Errol Zeiger Genotoxic and Nongenotoxic Mechanisms of Carcinogenesis Wai Nang Choy Structure-Activity Relationship (SAR) and its Roles in Cancer Risk Assessment David Y. Lai and Yin-tak Woo Regulatory Genetic Toxicology Tests Wai Nang Choy Complementary Genetic Toxicology Assays B. Bhaskar Gollapudi The Mouse Lymphoma Assay (MLA) Using the Microwell Method Masamitsu Honma and Toshio Sofuni The In Vitro Micronucleus Assay Marilyn J. Aardema and Micheline Kirsch-Volders ICH Guidelines on Genotoxicity and Carcinogenicity: Scientific Background and Regulatory Practice Lutz Müller, Peter Kasper, and Leonard Schechtman New OECD Genetic Toxicology Guidelines and Interpretation of Results Michael C. Cimino Dose-Response Relationships in Chemical Carcinogenesis and Cancer Risk Assessment Werner K. Lutz Molecular Epidemiology and Biomarkers Jia-Sheng Wang, Jonathan M. Links, John Groopman Quantitative Cancer Risk Assessment of Nongenotoxic Carcinogens Anna M. Fan and Robert A. Howd Risk Assessment of Genotoxic Carcinogens Lauren Zeise Biologically Based Cancer Risk Assessment Models Suresh H. Moolgavkar
£171.00
Taylor & Francis Inc Colorectal Cancer
Book SynopsisWritten by world authorities on the subject, this reference comprehensively covers every aspect of colorectal cancer. Addressing the molecular mechanisms, genetics, identification, and therapy of disease, this guide covers new pharmaceutical developments, current screening protocols, and modern methods of disease management by specialists at renowned institutions such as the Royal Marsden Hospital, the Memorial Sloan Kettering Cancer Center, and the Vanderbilt-Ingram Cancer Center.Table of ContentsGenetic Susceptibility to Colorectal Cancer. Epidemiology of Colorectal Cancer. Colorectal Cancer Screening. Pathology. Familial Cancer Management. The Surgical Principles of Managing Colorectal Cancer. Adjuvant Therapy for Colorectal Cancer. The Role of Radiotherapy in the Treatment of Rectal Cancer. Hepatic Directed Therapy. Pharmacogenomics of Colorectal Cancer. Drug Development for Advanced Colorectal Cancer in the U.S.
£171.00
Taylor & Francis Inc Radionuclide Peptide Cancer Therapy
Book SynopsisOffering lower toxicity and higher accuracy than conventional therapies, this source offers illustrative coverage of this new method to treat tumors associated with brain, breast, lung, and neuroendocrine cancers. Accompanied by a CD offering color images, radiolabeling procedures, and tips on radiopharmceutical administration, this source will offer comprehensive and expert guidance on this burgeoning therapeutic technique.Table of ContentsTHEORY AND PRODUCTION OF PEPTIDES FOR RADIONUCLIDE THERAPY. Peptide Structure and Analysis. Molecular Pharmacology of Receptors. Receptors Distribution and Biochemical Characterization. RADIOLABELING MECHANISMS AND STRATEGIES. Developments of Radiolabeled Peptides. Receptor Targeting for Tumor Therapy with Radiopeptides. New Radionuclides for Peptide Therapy. Pre-Clinical Comparison of Radiolabeled Peptides for Radionuclide Therapy. CLINICAL THERAPEUTIC APPLICATIONS. Phase I Therapeutic Studies. Response to Treatment with Radiolabeled Peptides. Receptor Radionuclide Therapy: From 90Y to 177Lu Labeled Peptides. Therapeutic Potential of Radiolabeled Peptides with Beta and Alpha Emitters. Receptor-Mediated Radionuclide Therapy: The European Institute of Oncology Experience. DOSIMETRIC ASPECTS AND REGULATORY REQUIREMENTS. Radiation Dosimetry in Preparation to Therapy. Dosimetry and Critical Organs. Regulatory Requirements for Therapy Trials. FUTURE PERSPECTIVES. Advances in the Field of Radiopeptides for Therapy
£171.00
Taylor & Francis Inc Neoplasms of the Colon Rectum and Anus
Book SynopsisColorectal cancer is the second-leading cause of cancer-related death in the Western World. This Second Edition analyzes the genetics, mechanisms, and development of colorectal carcinoma and supplies the latest research and recommendations on the detection, treatment, and prevention of malignancies of the colon, rectum, and anus.Table of ContentsBenign Neoplasms of the Colon and Rectum. Large Bowel Carcinoma: Screening, Surveillance, and Follow-up. Malignant Neoplasms of the Colon. Malignant Neoplasms of the Rectum. Perianal and Anal Canal Neoplasms. Anal and Transanal Techniques. Laparoscopic Colon and Rectal Surgery.
£454.91
Taylor & Francis Inc Metal Ions in Biological Systems
Book SynopsisOffering an authoritative and timely account by twenty-nine internationally recognized experts, Metal Ions in Biological Systems: Metal Complexes in Tumor Diagnosis and as Anticancer Agents is devoted solely to the vital research area concerning metal complexes in cancer diagnosis and therapy. In fourteen stimulating chapters, the book focuses on diagnostic tools such as magnetic resonance imaging (MRI), luminescent probes, and radiopharmaceuticals, including radiometallo-labeled peptides and assesses the role of metal ions, especially iron, in the action of antibiotics employed in anticancer chemotherapy.Trade Review"This is one of two recent volumes in a most successful series publishes since 1973 and which enjoys world renown and respect as both reference and as training material; the current volume is no exception. … [T]his is a gem of a book for both newcomers and established researchers in the field; long may they continue!" - Applied Organometallic Chemistry, 2005Promo CopyTable of ContentsMagnetic Resonance Contrast Agents for Medical and Molecular Imaging. Luminescent Lanthanide Probes as Diagnostic and Therapeutic Tools. Radio-Lanthanides in Nuclear Medicine. RadioMetallo-Labeled Peptides in Tumor Diagnosis and Therapy. Cisplatin and Related Anticancer Drugs. Recent Advances and Insights. The Effect of Cytoprotective Agents in Platinum Anticancer Therapy. Antitumor Activity of Trans-Platinum Species. Polynuclear Platinum Drugs. Platinum(IV) Anticancer Complexes. Ruthenium Anticancer Drugs. Antitumor Titanium Compounds and Related Metallocenes. Gold Complexes as Antitumor Agents. Gallium and Other Main Group Metal Compounds as Antitumor Agents. Metal Ion Dependent Antibiotics in Chemotherapy.
£454.91
Taylor & Francis Inc Molecular Carcinogenesis and the Molecular
Book SynopsisTo gain a complete overview of what is presently known about molecular carcinogenesis would prove to be a very daunting task for those not already steeped in this complex subject. Fortunately, David Warshawsky and Joseph Landolph Jr., both highly respected for their own contributions to the field, know exactly whom to call upon to fulfill the need for a definitive summary.Molecular Carcinogenesis and the Molecular Biology of Human Cancer provides a technical, as well as historical, overview of research covering the science of cancer. This volume explores molecular information specific to chemical, viral, and radiation carcinogenesis, explains the working of cellular oncogenes and tumor suppressor genes, and also introduces readers to the latest genomic and proteomic approaches. The first part of the book offers basic information; the second part deals strictly with cancer in humans. It commences with discussions on induction and exposure, then reviews complex mixtureTable of ContentsHistorical Perspective and Overview. Whole Animal Carcinogenecity Bioassays: Initiation and Promotion. Classes of Carcinogens. Metabolic Activation of Chemical Carcinogens. DNA Binding of Carcinogens to DNA and Covalent Adducts and DNA Damage-Mechanisms of Carcinogenesis. Mutagenesis and Genetic Toxicology. Chemically Induced Morphological and Neoplastic Transformation. Viral Carcinogenesis. Oncogene Activation and Chemical Carcinogenesis. Tumor Suppressor Gene Inactivation and Chemical Carcinogenesis. Radiation Carcinogenesis. Overview of Human Cancer Induction and Human Exposure to Carcinogens. Lung Cancer. Skin Cancer. Other Chemically Induced Cancers. Mixtures of Chemical Carcinogens: Principles of Action and Human Exposure. Risk Assessment and Regulation of Carcinogens. Chemoprevention of Chemical Carcinogenesis and Human Cancer.
£999.99
Taylor & Francis Inc Cutaneous TCell Lymphoma
Book SynopsisCutaneous T-cell lymphoma (CTCL) is a general term for many lymphomas of the skin including mycosis Fungoides and Sezary syndrome. This book presents the state of the art in CTCL epidemiology, clinical features, pathology, immunochemistry, diagnostic molecular techniques, staging and prognosis, and treatment. Edited by one of the leading experts in the disease, Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrome provides comprehensive coverage of the disease and presents techniques for diagnosis and state-of-the-art treatment modalities, such as ultraviolet light, steroids, and topical chemotherapeutics.Table of ContentsCutaneous T-cell lymphoma (CTCL) is a general term for many lymphomas of the skin including mycosis Fungoides and Sezary syndrome. This book presents the state of the art in CTCL epidemiology, clinical features, pathology, immunochemistry, diagnostic molecular techniques, staging and prognosis, and treatment. Edited by one of the leading experts in the disease, Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrome provides comprehensive coverage of the disease and presents techniques for diagnosis and state-of-the-art treatment modalities, such as ultraviolet light, steroids, and topical chemotherapeutics.
£161.50
Taylor & Francis Inc NutrientGene Interactions in Cancer
Book SynopsisThe complete mapping of the human genome, along with the development of sophisticated molecular technologies, has accelerated research on the relationship between nutrients and genes. This has led to compelling evidence garnered from epidemiological and experimental observations supporting the idea that the interaction between nutrients and genes is one of the most important mechanisms influencing carcinogenesis. Nutrient-Gene Interactions in Cancer brings together leading authorities in the field who provide an overview and look specifically at the mechanisms known to underlie each nutrient and gene interaction. The book examines the multi-functional relationship linking nutrition and cancer development, including the complex role nutrients have in modulating cancer growth via interactions with specific genes, and the emerging new strategy for cancer chemoprevention that is based on a deepened understanding of this relationship. The authors also provide freshly illuminating inTable of ContentsNutrients and Genes Interaction. Candidate Mechanisms for the Nutrients and Gene Interaction. Biomarkers for Nutrients and Gene Interaction. Folate and Methylenetetrahydrofolate Reductase Gene. Folate and One-Carbon Metabolism Genes. Methionine and Methionine Adenosyltransferase. b -Carotene and Retinoic Receptor Genes. Vitamin D and Vitamin D Receptor Gene. Alcohol and Alcohol Dehydrogenase Genes. Meat and N-Acetyltransferase 2 Gene. Dietary Estrogens and Estrogen Receptor Genes. Ferritin and Serine Hydroxymethyltransferase Gene. Isothiocyanate and Glutathione S-Transferase Gene. Future Directions and Implication of Research on Nutrients and Gene Interactions in Cancer.
£210.00
Taylor & Francis Inc Nutrition and Cancer Prevention Nutrition and
Book SynopsisEpidemiological studies have estimated that approximately 35 percent of cancers are potentially avoidable by nutritional modification. These modifications include strategies such as caloric restriction and limitation of specific macro-nutrient groups. However, recent research indicates that what you eat may well be just as important as what you shun when it comes to avoiding cancer, especially colon, breast, and prostate cancers, which have become epidemic in the Western hemisphere. Nutrition and Cancer Prevention brings together the top experts in nutritive health who present significant evidence that specific dietary micronutrients have the potential to play a role in resisting cancer, modulating its development, or reducing tumor metastasis. As a way of introduction, the book updates the descriptive epidemiology of the major cancers of the Western world, and then discusses the likely mechanisms of action that occur when certain essential nutrients become diet staples. TTable of ContentsIntroduction. Dietary Components that Protect from Cancer: Vitamins. Dietary Components that Protect from Cancer: Minerals. Dietary Components that Protect from Cancer: Phytosterols. Dietary Components that Protect from Cancer: Polyphenols. Dietary Components that Protect from Cancer: Isothiocyanates. Dietary Components that Protect from Cancer: Saponins., Dietary Components that Protect from Cancer: Specialized Lipids. Dietary Cancer Risk Factors.
£185.25
Taylor & Francis Inc Initiation and Promotion in Skin Or Liver
Book SynopsisInitiation and Promotion in Skin or Liver Neoplasia is the only source of its kind that presents a comprehensive compilation of in vivo initiation/promotion studies that involve neoplastic changes in the skin or liver of experimental animals. The book surveys world literature over the past 65 years from almost 2,000 original studies covering nearly 200 journals in 9 languages. Publications reviewed consist of primary peer-reviewed papers, as well as those abstracts, meeting reports, and review articles, containing original data. Papers measuring both pre-neoplastic or neoplastic changes are included.The summaries for each study included in the book are highly formatted resumes that have four principal components which indicate:1) What was done in the study;2) How the study was done (e.g, methods);3) The precise results obtained;4) Individual critiques using GLP (Good Lab Practice) standards.Initiation and Promotion in Skin or Liver Neoplasia provides an indispensable abstracted reference resource for scientists, toxicologists, cancer researchers, litigators, regulators, environmentalists, policy analysts, and industry-based investigators.Table of ContentsSection A: Skin Entries, Alphabetic by First Author. Section B: Liver Entries, Alphabetic by First Author. Index 1: Skin, Alphabetic by Initiator. Index 2: Skin, Alphabetic by Promoter. Index 3: Liver, Alphabetic by Initiator. Index 4: Liver, Alphabetic by Promoter. References.
£999.99
Taylor & Francis Inc Thyroid Diseases
Book SynopsisThyroid Diseases: Clinical Fundamentals and Therapy provides a wide-ranging examination of all clinically significant areas of thyroid diseases. Underlying physiological principles are closely linked to the clinical situation and practical therapeutic interventions. The book examines the clinical course, therapy, and final outcome of thyroid diseases, particularly the bimodal and transient evolution of several thyroid diseases. It also discusses the medical, surgical, and radiometabolic therapy of thyroid diseases, stressing the pros and cons of each therapeutic modality. More than 80 acknowledged experts from North America, Europe, and Japan have contributed to this exceptional reference volume, making it essential for physiologists, clinical endocrinologists, radiologists, researchers in nuclear medicine, oncologists, and radiotherapists.Table of ContentsClassification: Classification of Thyroid Diseases (F. Monaco). Euthyroidism: Diffuse and Multinodular Nontoxic Goiter (J.T. Dunn). Hyperthyroidism: Diffuse Toxic Goiter (Basedow-Flajani-Graves' Disease) (S. Nagataki, H. Tamai, and S. Yamashita). Toxic Nodular Goiter (J. Orgiazzi and R. Mornex). Unusual Forms of Thyrotoxicosis (S. Mariotti, E. Macchia, and A. Pinchera). Iodine-Induced Thyrotoxicosis (L. Chiovato, P. Vitti, and A. Pinchera). Transient Hyperthyroidism (G. Napolitano and F. Monaco). TSH-Secreting Pituitary Adenomas (P. Beck-Peccoz and G. Faglia). Thyroid Crisis (F. Monaco and M.A. Satta). Hypothyroidism: Congenital Hypothyroidism and Screening (T.P. Foley, Jr). Adult Acquired Hypothyroidism (A. Ermans). Biosynthetic Defects in Thyroid Hormonogenesis (G. Medeiros-Neto). Pituitary and Hypothalmic Hypothyroidism (G. Faglia and P. Beck-Peccoz). Subclinical and Transient Hypothyroidism (M. D'Armiento). Hypothyroid Coma (F. Monaco and M.A. Satta). Resistance to Thyroid Hormones: Syndromes of Resistance to Thyroid Hormone (C.A. Meier and B.D. Weintraub). Thyroiditis: Acute Suppurative Thyroiditis (M. Centanni, S. Sciacchitano, and M. Andreoli). Subacute (De Quervain's) Thyroiditis (N. Amino and K. Takada). Chronic Thyroiditis (M. Izumi). Postpartum and Silent Thyroiditis (N. Amino). Tumors: The Thyroid Nodule (S.G. Jackson and L. Wartofsky). Differentiated Thyroid Carcinoma (A.J. Van Herle and A.J. Lutz). Anaplastic Thyroid Carcinoma (M. Schlumberger). Medullary Thyroid Carcinoma (M. Schlumberger, P. Gardet, and C. Parmentier). Ophthalmopathy: Graves' Ophthalmopathy: Diagnosis, Pathogenesis, Prognosis, Treatment (R. Mornex and J. Orgiazzi). Therapy: Medical Therapy (F. Monaco). Surgery in the Management of Thyroid Diseases (N.W. Thompson). Metabolic Radiotherapy of Thyroid Disease: General Principles (B. Shapiro and L. Troncone). The Metabolically Directed Radiotherapy of Hyperthyroidism with Radioiodine (B. Shapiro and L. Troncone). The Metabolically Directe
£999.99
Taylor & Francis Inc Transformation of Human Diploid Fibroblasts
Book SynopsisThis comprehensive publication draws together the important aspects of carcinogen-cell interaction. This interesting work describes the regulation of normal cell proliferation, cellular responses to carcinogen damage, the biologic consequences of cellular DNA modification, the structural and genomic changes resulting from carcinogen insult, and the possible involvement of such changes in the conversion of normal human fibroblasts to malignant cells. It presents current reviews with up-to-date literature references and provides critical information from leading investigators that is essential in understanding the biology of human cell transformation. This volume is especially useful to advanced students in genetic toxicology, molecular biologists, and all who are interested in the molecular and macromolecular changes in human cells leading to neoplasia.Table of ContentsPreface. Variations in Susceptibility to Initiation of Carcinogenesis During the Cell Cycle. Cell Cycle Regulation of DNA Repair Enzymes and Pathways. DNA Repair and Poly(ADP-ribose) Synthesis in Human Fibroblasts and Other Cell Types. Repair of O-Alkylation Damage in Human Cells. Ultraviolet Radiation-Induced Transformation of Human Cells. Biological Characterization and Quantitation of Markers of Transformation of Human Fibroblasts. Mechanisms for Cell Transformation and Carcinogenesis by Genotoxic and Nongenotoxic Agents: Role of Sodium Saccharin. Relationship Between Bulky Carcinogen-DNA Modification: Carcinogenesis and Mutagenesis. Metabolism of Polyaromatic Hydrocarbons by Human Fibroblasts. DNA Adducts and Human Cell Transformation. Cytotoxicity and Cell Culture. Mechanisms by Which Phorbol Ester Tumor Promoters Affect Gene Expression in Human Cells. Changes in Gene Expression Associated with Neoplastic Transformation of Human Fibroblasts: The Abundant Cellular Proteins. Differential Repair of Damage in Specific DNA Sequences of Human Cells. Index.
£999.99
Taylor & Francis Inc Papillomaviruses and Human Cancer
Book SynopsisThis volume gives special reference to papillomaviruses in benign precursor lesions related to genital tumors, plus it provides a basis for a more reproducible evaluation of the pathology of papillomavirus-induced lesions. It deals with the molecular biology of papillomaviruses as it relates to our understanding of viral cell transformation and malignant conversion. Written in a comprehensive, easy-to-read format, this book covers points of medical interest such as diagnosis, therapy, and prospects for vaccination. This fascinating text provides current, state-of-the-art practices for immediate and future medical research. Virologists, microbiologists, and cancer researchers will find this work interesting and resourceful.Table of ContentsGeneral Introduction to Papillomaviruses. Association of Human Papillomavirus with Benign, Premalignant and Malignant Anogenital Lesions. Human Papillomaviruses in Skin Carcinomas. Papillomaviruses and Human Cancer. Bovine Papillomavirus Type 1 Transcription. The Genetics of Bovine Papillomavirus Type 1. Cell Transformation by Human Papillomaviruses. State of Viral DNA and Gene Expression in Benign vs. Malignant Tumors. Papillomavirus Genomes: Sequence Analysis Related to Functional Aspects. Therapy of Papillomavirus Induced Lesions. Detection of Human Papillomavirus Infection and Prospects for Diagnostics. Immunobiology of Papillomaviruses and Prospects for Vaccination. Index.
£999.99
Taylor & Francis Inc Hormones and Vitamins in Cancer Treatment
Book SynopsisHormones and Vitamins in Cancer Treatment is intended to serve as a therapeuticial guide for physicians using non-aggressive methods, such as hormonotherapy and vitamin therapy, when treating cancer patients. This book provides the rationale and scientific basis for hormones and vitamins, which play an important role in cancer management, and emphasizes the significance of hormones and vitamins in chemoprevention and chemoprophylaxis of cancer. Topics discussed in this book include the criteria for selecting patients for hormonotherapy and vitamin therapy; the favorable effects and advantages of hormonotherapy and vitamin therapy over (or used as adjuvant therapeutic agents) more aggressive methods, such as chemotherapy, radiation therapy, immunotherapy or surgery; and hormone-like substances, such as growth factors, interferons, interleukins, and prostoglandins. Also included is the newest information regarding the role of diet in cancer prevention. This book is packed with valuable iTable of ContentsPrinciples and Rationale for Hormone and Vitamin Therapy in Cancer. Hormones and Hormonotherapy. Hormone Antagonists and Hormone Agonists. Hormone-Like Substances: Clinical and Therapeutic Implications. Vitamins-Vitamin Therapy. Advantages and Disadvantages of Hormonotherapy and Vitamin Therapy. Chemoprevention of Cancer by Hormones and Vitamins. Diet, Hormones, Vitamins and Cancer.
£999.99
Taylor & Francis Inc Intraoperative Radiation Therapy
Book SynopsisA comprehensive review of intraoperative radiation therapy, beginning with the rationale for innovative treatment and the radiobiology of single doses. Problems encountered in modifying a linear accelerator and a radiation therapy suite are reviewed in detail along with special problems relating to technology, nursing, anesthesiology, and various surgical subspecialties. Intraoperative radiation therapy applicators and dosimetric considerations are also reviewed. This text is a valuable reference tool for institutions planning to develop or construct intraoperative radiation therapy facilities.Table of Contents1. History of Intraoperative Radiation Therapy 2. The Rationale for Intraoperative Radiotherapy 3. Radiobiology of Large Radiation Fractions 4. Application of Dose-Effect Relationships to Intraoperative Radiotherapy 5. Physical Aspects and Dosimetric Considerations for Intraoperative Radiation Therapy with Electron Beams 6. Physical Aspects of Intraoperative Radiation Therapy 7. Anesthesiologic Considerations for Intraoperative Radiation Therapy 8. Nursing and Technological Considerations in Intraoperative Radiation Therapy 9. The Development of an Intraoperative Radiation Therapy Program — The Groningen IORT Project 10. The Role of Orthovoltage Equipment for Intraoperative Radiation Therapy 11. The Use of Superficial X-Ray Equipment for Intraoperative Radiation Therapy 12. General Surgical Aspects of Intraoperative Radiation Therapy 13. Neurosurgical Considerations in Intraoperative Radiation Therapy 14. Intraoperative Radiation Therapy for Malignant Brain Tumors 15. Intraoperative Radiation Therapy for Advanced or Recurrent Head and Neck Malignancies 16. Intraoperative Radiation Therapy for Gastric Cancer 17. Intraoperative Radiation Therapy for Pancreatic Cancer in Japan 18. Intraoperative Radiation Therapy in Combination with Computer-Controlled Conformation Radiotherapy for Pancreatic Cancer 19. Intraoperative Radiation Therapy for Bladder Cancer 20. Intraoperative Radiation Therapy for Bladder Cancer: A Review of Techniques Allowing Improved Tumor Doses and Providing High Cure Rates without the Loss of Bladder Function 21. Intraoperative Radiation Therapy for Prostatic Cancer 22. Intraoperative Electron Beam Radiation Therapy for Gynecological Malignancies 23. Intraoperative Radiation Therapy for Colorectal Cancer 24. Intraoperative Radiation Therapy of Soft Tissue Sarcomas 25. Intraoperative Radiation Therapy at the Massachusetts General Hospital 26. Mayo Clinic Experience with Intraoperative and External Beam Irradiation with or without Resection 27. The Rus
£999.99
Taylor & Francis Inc Prostaglandin Inhibitors in Tumor Immunology and
Book SynopsisThis book provides an updated overview of eicosanoid metabolism. It also presents a timely discussion of eicosanoid metabolism in the process of tumor cell metastasis, in chemoprotection and radioprotection associated with cancer therapy, and in cell differentiation. The book focuses on the role of eicosanoids in the immunology of malignant disease. This includes how various immune cell populations in cancer are affected by the secretion and action of various eicosanoids and metabolites of eicosanoids and how these processes may be affected by various pharmacological manipulations and interventions to augment anti-tumor immunity. Head and neck cancer is covered in great detail to illustrate a cancer in humans where these considerations are particularly relevant. This important volume demonstrates that the principal factor in cancer patient immunologic deficiency is related to excess secretion by monocytes of prostaglandins.Table of ContentsCyclooxygenase and Lipoxygenase Pathways of Arachidonic Acid Metabolism (W.L. Smith and O. Laneuville). Participation of Lipoxygenase Products in Lymphohematopoietic and Other Cell Proliferation and Differentiation (K.M. Anderson, M. Wiederhold, and F. Ondrey). Eicosanoids and Tumor Cell Metastasis (D.G. Tang and K.V. Honn). The Impact of Prostaglandins on Cancer Patient Immunity (D.P. Braun and J.E. Harris). Prostaglandins and Host Immune Response in Squamous Cell Carcinoma of the Head and Neck (D.S. Cross, F. Ondrey, S.K. Juhn, and G.L. Adams). Eicosanoid-Induced Radioprotection and Chemoprevention of Normal Tissue During Cancer Treatment (W.R. Hanson). Prostaglandins and the Host Immune System: Application of Prostaglandin Inhibitors for Cancer Immunotherapy (P.K. Lala and M.-N. Saarloos).
£999.99
Taylor & Francis Inc Developmental Biology and Cancer
Book SynopsisThis book addresses possible analogies between cancer and developmental biology. An international group of experts provides a multidisciplinary approach, allowing biological or clinical scientists involved with cancer research to integrate specific information from diverse areas.Five concepts of cancer are presented, and developmental biology is reviewed at five levels. These are integrated in discussions of failure in organisation as a basis of cancer and its control. The book will be a valuable reference for both newcomers as well as experienced biological and clinical scientists. FeaturesTable of ContentsThe Concept of Cancer and Operational Conditions for Carcinogenesis: Pathology of Neoplasia: Morphological and Functional Attributes (H.G. Augustin-Voss and B.U. Pauli). Relative Malignancy and Ontogeny (C. Rowlatt). Epigenetic Nature of Neoplastic Transformation (H. Rubin). Linkages in the Control of Differentiation, Proliferation, and Anticancer/Cancer-Suppressor Activitiy: Defects in Carcinogenesis (R.E. Scott, S.P. Blatti, R. Parker, L.R. Solomon, C.-Y. Tzen, H. Wang, and M.M. Witte). Age-related Factors in Carcinogenesis (V.M. Dilman). Relevant Organizational Processes Revealed by Developmental Biology: Patterning and Morphogenesis and the Development of Organized Tissues (C. Tickle). Biology and Mechanisms of Tissue Interactions in Developing Systems (B.K. Hall). Cell Lineages, Fate Determination, and Differentiation Pathways (P.P.L. Tam). The Role of the Cytoskeleton in the Relationship Between Cell Shape, Gene Expression, and Morphogenesis (A. Ben Ze'ev). Mediators of Cell Growth and Differentiation (C.L. Mummery and P.T. van der Saag). Failure of Organizational Processes as a Basis of Neoplastic Behavior and Its Control: Genetics of Cancer Predisposition (M.F. Hansen). Physiological Roles of Oncogenes in Development and Neoplasia (M. Donovan, S. Demczuk, G. Franklin, and R. Ohlsson). Invasiveness in Development and Neoplasia (M. Mareel, F. Van Roy, P. De Baetselier, and L. Vakaet). Dysfunction of Regulatory Tissue Interactions (G.M. Hodges). Differentiation Therapy of Cancer (S.T.A. Malik). Genetic Intervention in the Control of Neoplasia (I. Magrath, K. Bhatia, and B. Huber).
£999.99
Taylor & Francis Inc New Techniques in Oncologic Imaging
Book SynopsisExploring a wide spectrum of oncologic imaging technologies with current and future applications ranging from ultrasound and PET to MRI, this reference analyzes recent developments concerning every available imaging technique-furnishing the most up-to-date research on technological advances in cancer imaging and their potential impact on patient care and treatment.Trade Review"…This book provides a very good overview of oncologic imaging techniques….It is a wonderful way to begin to grasp the changes that have occurred in oncologic imaging and the exciting technologies on the horizon."-Doody's ReviewsTable of ContentsAdvances in Mature Imaging Technologies. Advances in CT. Advances in MRI. Advances in Ultrasound. Contrast Media Developments. MR Lymphography. Image Processing. Radiotherapy Planning. New Imaging Technologies. PET in Oncology. PET Advances. Nuclear Medicine (Non-PET). MRS in Oncology. Dynamic MRI. Perfusion CT. BOLD Imaging of Tumors. Promising "New Breed" Technologies. PK/PD Imaging. Molecular Imaging. Diffusion Imaging in Tumors. Electron Spin Resonance. Optical Imaging
£109.25
Taylor & Francis Inc Artificial Neural Networks in Cancer Diagnosis
Book SynopsisThe potential value of artificial neural networks (ANN) as a predictor of malignancy has begun to receive increased recognition. Research and case studies can be found scattered throughout a multitude of journals. Artificial Neural Networks in Cancer Diagnosis, Prognosis, and Patient Management brings together the work of top researchers - primarily clinicians - who present the results of their state-of-the-art work with ANNs as applied to nearly all major areas of cancer for diagnosis, prognosis, and management of the disease.The book introduces the theory of neural networks and the method of their application in oncology. It is not an exercise in ANN research, but the presentation of a new technique for diagnosing and determining the treatment of cancers. The authors have included almost all cancers for which there exist ANN applications. When the data available is ill-defined and the development of an algorithmic solution difficult, neural networks provide a non-linear approTable of ContentsIntroduction to Artificial Networks and Their Use in Cancer Diagnosis, Prognosis, and Patient Management. Analysis of Molecular Prognostic Factors in Breast Cancer by Artificial Neural Networks. Artificial Neural Approach to Analysing the Prognostic Significance of DNA Ploidy and Cell Cycle Distribution of Breast Cancer Aspirate Cells. Neural Networks for the Estimation of Prognosis in Lung Cancer. The Use of a Genetic Algorithm Neural Network (GANN) for Prognosis in Surgically Treated Non-Small Cell Lung Cancer (NSCLC). The Use of Machine Learning in Screening for Oral Cancer. Outcome Prediction of Oesophago-Gastric Cancer Using Neural Analysis of Pre- and Post-Operative Parameters. Artificial Neural Networks in Urologic Oncology. Neural Networks in Urologic Oncology. Comparison of a Neural Network with High Sensitivity and Specificity to Free/Total Serum PSA for Diagnosing Prostate Cancer in Men with PSA. Artificial Neural Networks and Prognosis in Prostate Cancer. Comparison Between Urologists and Artificial Neural Networks in Bladder Cancer Outcome Prediction. A Probabilistic Neural Network Framework for Detection of Malignant Melanoma.
£161.50
Baywood Publishing Company Inc Robbery and Redemption
Book SynopsisFirst Published in 2017. This volume is a totally candid account about the facts and feelings surrounding the diagnosis of and battle against lung cancera battle the author waged with every ounce of his being. It has an enlightening quality because he shares how he transformed his previous knowledge of family dynamics, coping strategies, and empowerment into wisdom. He shares his journey of taking the knowledge from the Before Cancer phase of his life, and like an alchemist, converting one raw materialhis life and his diagnosis and battleinto an element quite unlike the original. Robbery and Redemption: Cancer as Identity Theft is chock-full of wisdom that has been learned the old fashioned, visceral wayfrom lived experience and keen reflection. This personal, upfront, rubber-hit-the-road treatise is a gift from the author to each reader. It is his wise interpretation of his own experiences of integrating values, problem solving, and coping strategies.Table of ContentsForeword Acknowledgments INTRODUCTION Read the Introduction now CHAPTER 1 The Dream CHAPTER 2 Through the Looking Glass CHAPTER 3 The Cancer Journey and Detours Along the Way CHAPTER 4 Resolving to Battle the Bully CHAPTER 5 Communicating with Cancer CHAPTER 6 Trying To Be An Exceptional Patient CHAPTER 7 A Cancer Apprentice: Lessons in Redemption EPILOGUE: Remembering Craig Index
£69.99